About morquio syndrome

What are the treatments for morquio syndrome?

The skeleton is typically affected by the uncommon genetic metabolic condition known as morquio syndrome.

The specific GAG that accumulates in the body during Morquio Syndrome is known as keratan sulfate. This lysosomal storage disorder is a form of the autosomal recessive birth condition. GAG accumulation in many body regions results in symptoms in numerous organ systems.

Treatment

1. The therapy of physical symptoms, which frequently necessitates a multifaceted approach across several different medical disciplines, is the primary line of treatment for Morquio syndrome.

2. Decompression surgery: As skeletal abnormality frequently causes compression of the upper neck and base of the skull, surgery may be necessary to relieve this pressure and enhance stability in the area.

3. Cardiac surgery: The surgical insertion of a prosthetic valve may be required when the heart is constrained by the narrower, less-developed rib cage that is associated with the syndrome.

4. Procedures for the airways: One of the most dangerous symptoms of Morquio syndrome is obstruction of the airways. Surgery may consequently be required to remove swollen tonsils and adenoids.

5. Those who experience clouding of the eyes may require a corneal replacement, according to specialists (keratoplasty).

Symptoms
A spine that is clearly curved (i.e. scoliosis or kyphosis),Eye corneas that are cloudy,Cardiac murmur,An inguinal hernia,An enlarged liver,Decrease in nerve activity below the neck
Conditions
Injury to the spinal cord, which could cause paralysis,Blindness, airway narrowing and breathing issues, which may lead to repeated upper respiratory infections,Heart attack,Impairment of hearing
Drugs
Vimizim,Elosulfasa alfa

What are the risk factors for morquio syndrome?

The skeleton is typically affected by the uncommon genetic metabolic condition known as morquio syndrome.

Morquio syndrome, often known as mps iv, is a condition that falls under the umbrella term mucopolysaccharidosis (mps). The inability of the organism to break down lengthy sugar chains known as glycosaminoglycans characterizes mps (formerly known as mucopolysaccharides). These chemicals consequently accumulate in the body and obstruct cell function.

The development of healthy bone, cartilage, corneas, skin, and connective tissue, such as tendons and ligaments, depends heavily on glycosaminoglycans.

Risk factor

1. Both men and women are at the same level of danger. All people have four to five defective genes. Consanguineous parents are more likely than unrelated parents to share a defective gene, which raises the likelihood that their offspring may develop a recessive genetic condition.

2. Morquio syndrome does not appear to result in intellectual deficits, in contrast to several other kinds of MPS.

Prognosis

Patients with different subtypes of Morquio syndrome have different life expectancies. With a life expectancy in the 20s to 30s, Type A is usually severe. A Morquio syndrome patient passed away in 2016 at the age of 81.

Symptoms
A spine that is clearly curved (i.e. scoliosis or kyphosis),Eye corneas that are cloudy,Cardiac murmur,An inguinal hernia,An enlarged liver,Decrease in nerve activity below the neck
Conditions
Injury to the spinal cord, which could cause paralysis,Blindness, airway narrowing and breathing issues, which may lead to repeated upper respiratory infections,Heart attack,Impairment of hearing
Drugs
Vimizim,Elosulfasa alfa

Video related to morquio syndrome